These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12081145)

  • 21. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A; Toi M; Nakayama K; Bando H; Mutoh M; Uchida T; Fukumoto M; Takebayashi Y
    Jpn J Cancer Res; 2001 Apr; 92(4):452-8. PubMed ID: 11346468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of reactive oxygen species on cell proliferation and death in HeLa cells and its MDR1-overexpressing derivative cell line.
    Liu YW; Sakaeda T; Takara K; Nakamura T; Ohmoto N; Komoto C; Kobayashi H; Yagami T; Okamura N; Okumura K
    Biol Pharm Bull; 2003 Feb; 26(2):278-81. PubMed ID: 12576695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-P-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cell line.
    Naito S; Hasegawa S; Yokomizo A; Koga H; Kotoh S; Kuwano M; Kumazawa J
    Jpn J Cancer Res; 1995 Nov; 86(11):1112-8. PubMed ID: 8567404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annexin-I expression modulates drug resistance in tumor cells.
    Wang Y; Serfass L; Roy MO; Wong J; Bonneau AM; Georges E
    Biochem Biophys Res Commun; 2004 Feb; 314(2):565-70. PubMed ID: 14733945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line.
    Hu XF; Slater A; Wall DM; Kantharidis P; Parkin JD; Cowman A; Zalcberg JR
    Br J Cancer; 1995 May; 71(5):931-6. PubMed ID: 7734315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cells resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.
    Loganzo F; Hari M; Annable T; Tan X; Morilla DB; Musto S; Zask A; Kaplan J; Minnick AA; May MK; Ayral-Kaloustian S; Poruchynsky MS; Fojo T; Greenberger LM
    Mol Cancer Ther; 2004 Oct; 3(10):1319-27. PubMed ID: 15486199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833.
    Beketic-Oreskovic L; Durán GE; Chen KG; Dumontet C; Sikic BI
    J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression.
    Takara K; Sakaeda T; Tanigawara Y; Nishiguchi K; Ohmoto N; Horinouchi M; Komada F; Ohnishi N; Yokoyama T; Okumura K
    Eur J Pharm Sci; 2002 Aug; 16(3):159-65. PubMed ID: 12128170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.
    Haga S; Hinoshita E; Ikezaki K; Fukui M; Scheffer GL; Uchiumi T; Kuwano M
    Jpn J Cancer Res; 2001 Feb; 92(2):211-9. PubMed ID: 11223551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
    Chao CC
    FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma.
    Yanagisawa T; Newman A; Coley H; Renshaw J; Pinkerton CR; Pritchard-Jones K
    Br J Cancer; 1999 Jun; 80(8):1190-6. PubMed ID: 10376971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743.
    Kanzaki A; Takebayashi Y; Ren XQ; Miyashita H; Mori S; Akiyama S; Pommier Y
    Mol Cancer Ther; 2002 Dec; 1(14):1327-34. PubMed ID: 12516966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
    Lacave R; Coulet F; Ricci S; Touboul E; Flahault A; Rateau JG; Cesari D; Lefranc JP; Bernaudin JF
    Br J Cancer; 1998 Mar; 77(5):694-702. PubMed ID: 9514046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and functional MDR1-Pgp and MRPs expression in human glioblastoma multiforme cell lines.
    Declèves X; Fajac A; Lehmann-Che J; Tardy M; Mercier C; Hurbain I; Laplanche JL; Bernaudin JF; Scherrmann JM
    Int J Cancer; 2002 Mar; 98(2):173-80. PubMed ID: 11857404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
    Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
    Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of increased lung resistance protein expression with acquired etoposide resistance in human H460 lung cancer cell lines.
    Lee E; Lim SJ
    Arch Pharm Res; 2006 Nov; 29(11):1018-23. PubMed ID: 17146971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of drug resistance is reduced with idarubicin relative to other anthracyclines.
    Hargrave RM; Davey MW; Davey RA; Kidman AD
    Anticancer Drugs; 1995 Jun; 6(3):432-7. PubMed ID: 7670142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of daunorubicin resistance in tumour cells by induction of carbonyl reduction.
    Ax W; Soldan M; Koch L; Maser E
    Biochem Pharmacol; 2000 Feb; 59(3):293-300. PubMed ID: 10609558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Let-7 modulates acquired resistance of ovarian cancer to Taxanes via IMP-1-mediated stabilization of multidrug resistance 1.
    Boyerinas B; Park SM; Murmann AE; Gwin K; Montag AG; Zillhardt M; Hua YJ; Lengyel E; Peter ME
    Int J Cancer; 2012 Apr; 130(8):1787-97. PubMed ID: 21618519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.